Can Lasa Supergenerics repeat its performance?

The company has restarted its mother unit situated at Chiplun, Maharashtra.

Lasa Supergenerics, a vertically integrated group spanning the entire animal and human healthcare value chain announced that the company has restarted its mother unit situated at Chiplun, Maharashtra. Recently in compliance with an order issued by Maharashtra Pollution Control Board (MPCB), Lasa Supergenerics Ltd had temporarily stopped its manufacturing activities.

The company has received an order from the Bombay High Court, setting aside disconnection of electricity and water supply on notice of MPCB and closure dated 06.10.2021 of MPCB shall not be acted on and it shall be treated as show-cause notice. Additionally, the High Court has also ordered MPCB for re-inspection in the matter of other units and restarts those units on satisfaction which was one of the reliefs we sought.

In August 2021 also the company had to stop its production due to floods, which they started within a week. Following the resumption of the operation, the share price of the company jumped by almost 17 per cent in a day.

The company has its unit with facilities located at Mahad, Maharashtra with a total installed capacity of 4,300 MT. The company offers a diverse mix of niche veterinary and human APIs, animal feed ingredients, and therapeutic reagents; serving ‘more than 300 customers’ across the animal and human healthcare value chain including the ‘multinational pharma companies, dairy and poultry industry, and small domestic formulators and traders’. Oxyclozanide was one of the key products that was going to be launched but did not due impact of floods in the region. The company is all set to restart the launch activities of this product, which will boost its overall topline in the coming quarters.

Lasa Supergenerics specializes in ‘catalyst chemistry’ and manufactures anthelmintic/veterinary API products with the largest production capabilities and product categories in India. The company has over 25 per cent of APIs exported to counties like Australia, Bangladesh, the Middle East, China, Turkey, Egypt, Jordan, Korea, etc. Besides, the company has a huge asset base with a big chunk of land bank for future expansion. The company's 100 per cent of business is out of patented products.